Citi Vet Joins Sciens Alternative Investments

Oct 26 2012 | 2:30pm ET

Sciens Capital Management Group has appointed Citi veteran Farhang Mehregani as chief investment officer of Sciens Alternative Investments.

Mehregani ran the Central & Eastern Europe, Middle East & Africa equities desk at Citi between 2008 and 2011. He also oversaw a $1 billion hedge fund seeding business at the bank and helped build out several European and Asian proprietary trading divisions. During his 15 years in the financial industry, Mehregani has worked in New York, London, Tokyo and Dubai.

In his new role, Mehregani will report to Stavros Siokos, chief executive of Sciens Alternative Investments, and will also be a member of the investment committee for the fund of funds business.

Said Siokos in a statement: "Farhang will focus on strategic initiatives that can leverage Sciens' strengths to offer institutional and high net worth investors a seamless entry point into the liquid alternative investments market."

The alternative investments arm of the business covers hedge funds, managed account services, investment services and advisory solutions.

The Sciens group manages approximately $4.8 billion and employs over 100 people globally with its principal offices in New York, London, Guernsey and Athens.


In Depth

Steinbrugge: Top 10 Hedge Fund Industry Trends for 2017

Jan 3 2017 | 9:03pm ET

Each year, Agecroft Partners' Don Steinbrugge predicts the top hedge fund industry...

Lifestyle

'Tis the Season: Wall Street Holiday Parties Back In Fashion

Dec 22 2016 | 9:23pm ET

Spending on Wall Street holiday parties has largely returned to pre-2008 levels...

Guest Contributor

DarcMatter: The Top Trends in Alternative Investments for 2017

Jan 13 2017 | 8:22pm ET

The $7 trillion alternative investments industry is poised for continued growth...

 

From the current issue of

The U.S. Commodity Futures Trading Commission (CFTC) ordered The Goldman Sachs Group Inc., and Goldman, Sachs & Co. to pay a $120 million penalty for attempted manipulation and false reporting of ISDAFIX Benchmark Rates, a global benchmark for interest rate products.